| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 696078 | Null | 0.0420420371076614 | -0.18129681 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0420420371076614 | -0.043716718 |
| NSC 726768 | 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline | 0.0420420371076614 | 0.15996018 |
| NSC 733906 | Null | 0.0420420371076614 | 0.37445785 |
| NSC 736164 | pyrazoline derivative | 0.0420420371076614 | -0.11324983 |
| NSC 740602 | Null | 0.0420420371076614 | -0.18378908 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0420420371076614 | 0.0097269856 |
| NSC 756166 | GSK312948A | 0.0420420371076614 | -0.12380906 |
| NSC 759216 | (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone | 0.0420420371076614 | 0.34963708 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0420420371076614 | -0.26647901 |